Soligenix to work with University of Hawaii, Hawaii Biotech on Ebola; Medigene's dendritic cell vaccines receive patent extention;

> Princeton, NJ-based Soligenix inked a collaboration agreement with the University of Hawaii at Manoa and Hawaii Biotech to work on a heat stable Ebola vaccine. Release

> The U.S. Patent Office extended Medigene's patent for dendritic cell vaccines to 2031. Brief

> Noting a potential for a hypertension vaccine, researchers found in a study of rats that three needless injections delivered lowered blood pressure for up to six months. More

> Research published in mBio suggests a protein called Niemann-Pick C1 to be the "Achilles' heel" of Ebola. More

Suggested Articles

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

Pfizer posted positive top-line results for a trial of its 20-valent pneumococcal vaccine, potentially setting up a filing by the end of 2020.

Univercells's new CDMO, Exothera, is hoping to play a role in helping drugmakers scale up manufacturing for a possible COVID-19 vaccine.